Picture [LSUS] – The Business Web Portal 650x65px
Document › Details

Kiadis Pharma N.V.. (10/19/18). "Press Release: Kiadis Pharma Raises €31.2 Million in a Private Placement of 3.9 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam.

Organisations Organisation Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
  Organisation 2 Jefferies International Ltd.
  Group Leucadia (Group)
Products Product ATIR101™ (Kiadis)
  Product 2 venture capital
Index term Index term Kiadis–SEVERAL: investment, 201810 private placment €31.2m with 3.9m new shares at €8/share
Persons Person Lahr, Arthur (Kiadis 201704– CEO before Crucell 200701 Chief Strategy Officer + EP Sales + BusDev)
  Person 2 Hård, Karl (Kiadis 201709–201812 Head IR + Communications LEFT 1/19 before Redx Pharma + AstraZeneca)

Record changed: 2019-03-08


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Kiadis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top